Excelsoft Technologies Limited has announced the approval of its unaudited financial results for the second quarter and half-year ended September 30, 2026. The Board of Directors considered and approved the Unaudited Financial Results (Standalone and Consolidated) as per Indian Accounting Standards. These results reflect the company’s financial performance during the specified periods, with the detailed statements enclosed for review.
Board Approves Financial Results
Excelsoft Technologies Limited convened a Board of Directors meeting on November 05, 2026, where the Unaudited Financial Results for the quarter and half-year ended September 30, 2026 were considered and approved. The results, prepared in accordance with Indian Accounting Standards (Ind-AS), encompass both standalone and consolidated financial statements. The company has provided the Limited Review Reports along with the financial results.
Key Financial Highlights
For the quarter ended September 30, 2026, Excelsoft Technologies reported a consolidated revenue from operations of INR 808.99 million. The profit after tax for the same period stood at INR 82.75 million. For the half-year ended September 30, 2026, the consolidated revenue from operations was INR 1,611.62 million, with a profit after tax of INR 175.03 million.
On a standalone basis, revenue from operations for the quarter ended September 30, 2026, was INR 809.30 million, and the profit after tax was INR 74.37 million. For the half-year ended September 30, 2026, standalone revenue from operations reached INR 1,612.71 million, with a profit after tax of INR 160.85 million.
IPO Utilization Update
The company also provided an update on the utilization of its Initial Public Offer (IPO) proceeds. As of September 30, 2026, a significant portion of the IPO proceeds has been utilized for funding capital expenditure, upgradation of IT infrastructure, and general corporate purposes. The unutilized net IPO proceeds are temporarily deposited and invested in monitoring accounts and fixed deposits.
Source: BSE
